As much as people want to express their views (based on no fact or understanding) that nothing is happening and no progress is being made, this announcement shows that many positive and very important things are happening behind the scenes to progress the company and its products to market. Great to see CE Mark registration progressed to Stage 2 and the Clinical studies being run by Professor Thompson starting imminently. The receipt of ethical approval from the institutions are out of the company's hands however are required to ensure the quality and depth of the studies and results. The fact that the company now has another highly reputable KOL in Professor Francis Thien, Director of Respiratory Medicine, Eastern Health who wants to be involved to actively assist the company to take its technology forward is very positive and powerful message/validation to the medical community of the benefit Wheezo will bring to Respiratory disease. The company will be in a great position with Professor Thompson and Professor Thien to showcase at the Annual Scientific Meeting of The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand.
The company continues to make good progress to achieving its milestones, attracting exceptional and highly reputable KOLs and has some of the very best technical, product, marketing and software specialist engaged to successfully launch Wheezo. Great things happening and looking forward to the next few weeks/months. Well done to the team!
- Forums
- ASX - By Stock
- Ann: Respiri progresses CE Mark registration
As much as people want to express their views (based on no fact...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSH (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.7¢ |
Change
-0.004(4.40%) |
Mkt cap ! $111.0M |
Open | High | Low | Value | Volume |
8.6¢ | 8.9¢ | 8.6¢ | $36.38K | 418.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.8¢ | 90000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 0.087 |
1 | 250000 | 0.085 |
2 | 200000 | 0.084 |
1 | 7000 | 0.082 |
1 | 147499 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.088 | 90000 | 2 |
0.089 | 7953 | 1 |
0.090 | 143000 | 2 |
0.091 | 317037 | 2 |
0.092 | 15000 | 1 |
Last trade - 11.03am 18/11/2024 (20 minute delay) ? |
Featured News
RSH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online